睿智医药 (300149.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(睿智医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 846,178,408.68557,454,592.06268,658,644.911,326,584,320.121,032,237,378.52686,896,517.51386,301,922.70
 营业利润(元) -34,688,682.63-18,517,565.47-31,830,300.91763,484,766.061,398,557,321.161,324,001,758.7311,449,336.64
 利润总额(元) -34,435,257.87-18,353,905.53-31,708,770.98744,722,019.001,398,101,253.611,323,761,733.9411,452,290.01
 净利润(元) -41,349,450.65-21,845,264.96-28,595,596.14378,378,016.591,023,227,946.22956,537,485.319,416,742.22
 归属于母公司股东的净利润(元) -41,203,766.78-21,775,906.44-28,566,911.66378,585,006.971,023,391,828.88956,584,663.079,470,996.67
盈利能力:
 销售毛利率(%) 23.6923.6827.1625.4236.0334.5039.57
 销售净利率(%) -4.89-3.92-10.6428.5299.13139.262.44
 净资产收益率(%) -1.54-0.83-1.33----
 总资产报酬率ROA(%) -0.71-0.44-0.39----
 投入资本回报率ROIC(%) -1.54-0.81-1.0612.6830.5228.980.30
营运能力:
 存货周转率(次) 12.0010.382.99----
 应收账款周转率(次) 2.521.640.72----
 总资产周转率(次) 0.210.140.07----
偿债能力:
 资产负债率(%) 30.9730.8132.4737.6035.4638.8452.73
 股东权益比率(%) 68.3268.4866.8361.7664.0260.6546.68
 已获利息倍数(倍) -5.33-52.38-0.9164.03-71.6569.371.57
 流动比率 1.621.641.481.751.801.640.63
 速动比率 0.770.800.751.161.311.240.18
发展能力:
 营业收入增长率(%) -18.02-18.84-30.45-21.54-18.17-18.75-0.87
 营业利润增长率(%) -102.48-101.40-378.01314.8210,537.68106,159.01458.93
 税后利润增长率(%) -104.03-102.28-401.63194.126,799.3518,518.34480.41
 净资产增长率(%) -22.63-19.7518.2720.2126.1923.23-18.19
 总资产增长率(%) -27.49-28.93-17.39-9.33-2.391.82-11.65

前瞻产业研究院